Cargando…
Biobanking of Exosomes in the Era of Precision Medicine: Are We There Yet?
The emerge of personalized medicine demands high-quality human biospecimens with appropriate clinical annotation, especially in complex diseases such as cancer, neurodegenerative, cardiovascular, and metabolic alterations in which specimen heterogeneity and individual responses often complicate the...
Autores principales: | Mora, Edna M., Álvarez-Cubela, Silvia, Oltra, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730260/ https://www.ncbi.nlm.nih.gov/pubmed/26712742 http://dx.doi.org/10.3390/ijms17010013 |
Ejemplares similares
-
Clinical applications for exosomes: Are we there yet?
por: Perocheau, Dany, et al.
Publicado: (2021) -
Precision Oncology: Are We There Yet?
Publicado: (2017) -
Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015) -
Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
por: Tran, Florian, et al.
Publicado: (2020) -
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021)